BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2888311)

  • 1. Chromosome 20 deletion in multiple endocrine neoplasia type 2: expanded double-blind studies.
    Babu VR; Van Dyke DL; Flejter WL; Jackson CE
    Am J Med Genet; 1987 Jul; 27(3):739-48. PubMed ID: 2888311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome 20 deletion in human multiple endocrine neoplasia types 2A and 2B: a double-blind study.
    Babu VR; Van Dyke DL; Jackson CE
    Proc Natl Acad Sci U S A; 1984 Apr; 81(8):2525-8. PubMed ID: 6585814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of the multiple endocrine neoplasia type 2B syndrome.
    Jackson CE; Norum RA
    Henry Ford Hosp Med J; 1992; 40(3-4):232-5. PubMed ID: 1362412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary medullary thyroid carcinoma: genetic annalysis of three related syndromes. Groupe d'Etude des Tumeurs a Calcitonine.
    Sobol H; Narod SA; Schuffenecker I; Amos C; Ezekowitz RA; Lenoir GM
    Henry Ford Hosp Med J; 1989; 37(3-4):109-11. PubMed ID: 2576938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of multiple endocrine neoplasia type 2A syndrome: linkage analyses and comparison of constitutional and tumor genotypes.
    Tateishi H; Takai S; Nishisho I; Miki T; Motomura K; Okazaki M; Miyauchi A; Ikeuchi T; Yamamoto K; Hattori T
    Henry Ford Hosp Med J; 1987; 35(2-3):157-60. PubMed ID: 2891649
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic mechanisms of neoplasia in MEN 2.
    Jackson CE; Norum RA
    Henry Ford Hosp Med J; 1989; 37(3-4):116-9. PubMed ID: 2576940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping the inherited defects associated with multiple endocrine neoplasia type 2A, multiple endocrine neoplasia type 2B, and familial medullary thyroid carcinoma to chromosome 10 by linkage analysis.
    Goodfellow PJ
    Endocrinol Metab Clin North Am; 1994 Mar; 23(1):177-85. PubMed ID: 7913024
    [No Abstract]   [Full Text] [Related]  

  • 8. Sublocalization of the multiple endocrine neoplasia type 1 gene.
    Larsson C; Weber G; Janson M
    Henry Ford Hosp Med J; 1992; 40(3-4):159-61. PubMed ID: 1362396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Where is the locus for multiple endocrine neoplasia type 2A?
    Simpson NE; Kidd KK
    Henry Ford Hosp Med J; 1987; 35(2-3):168-71. PubMed ID: 2891652
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnosis and treatment of syndrome of multiple endocrine neoplasia type 2].
    Kuznetsov NS; Bel'tsevich DG; Poliakova EIu; Vasil'ev EV; Nemtsova MV
    Khirurgiia (Mosk); 2002; (2):4-9. PubMed ID: 12418313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current perspectives on the diagnosis and management of patients with multiple endocrine neoplasia type 2 syndromes.
    Wells SA; Donis-Keller H
    Endocrinol Metab Clin North Am; 1994 Mar; 23(1):215-28. PubMed ID: 7913027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allele loss on chromosome 10 and point mutation of ras oncogenes are infrequent in tumors of MEN 2A.
    Okazaki M; Miya A; Tanaka N; Miki T; Yamamoto M; Motomura K; Miyauchi A; Mori T; Takai S
    Henry Ford Hosp Med J; 1989; 37(3-4):112-5. PubMed ID: 2576939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mapping of the locus for multiple endocrine neoplasia type 2A by linkage with chromosome 10 markers.
    Simpson NE; Kidd KK
    Horm Metab Res Suppl; 1989; 21():5-9. PubMed ID: 2572529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High resolution chromosome and DNA analysis in multiple endocrine neoplasia type II syndrome.
    Butler MG; Repaske DR; Joseph GM; Phillips JA
    Cancer Genet Cytogenet; 1987 Jan; 24(1):129-35. PubMed ID: 2878715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic testing in multiple endocrine neoplasia and related syndromes.
    Calender A
    Forum (Genova); 1998; 8(2):146-59. PubMed ID: 9666051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity of markers on chromosome 11 in tumors from patients with multiple endocrine neoplasia syndrome type 1.
    Radford DM; Ashley SW; Wells SA; Gerhard DS
    Cancer Res; 1990 Oct; 50(20):6529-33. PubMed ID: 1976436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary medullary thyroid carcinoma.
    Vasen HF; Vermey A
    Cancer Detect Prev; 1995; 19(2):143-50. PubMed ID: 7750101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cytogenetic study of familial medullary carcinoma of the thyroid.
    Wurster-Hill DH; Noll WW; Bircher LY; Devlin J; Schultz E
    Cancer Res; 1986 Apr; 46(4 Pt 2):2134-8. PubMed ID: 2418963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple endocrine neoplasia (MEN)--an overview and case report--patient with sporadic bilateral pheochromocytoma, hyperparathyroidism and marfanoid habitus.
    Fassbender WJ; Krohn-Grimberghe B; Görtz B; Litzlbauer D; Stracke H; Raue F; Kaiser HE
    Anticancer Res; 2000; 20(6C):4877-87. PubMed ID: 11205236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary analysis of consortium data for markers tightly linked to multiple endocrine neoplasia type 2A.
    Lichter JB; Hackleman SM; Ponder BA; Easton D; Narod SA; Lenoir GM; Gagel RF; Simpson NE; Gardner E; Goodfellow PJ
    Henry Ford Hosp Med J; 1992; 40(3-4):205-9. PubMed ID: 1362406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.